BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6351211)

  • 1. [Pyrithioxin in the treatment of patients with rheumatoid arthritis (comparative study with D-penicillamine)].
    Tosković B
    Reumatizam; 1983; 30(3):60-8. PubMed ID: 6351211
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sulfhydryl-based treatment of rheumatoid arthritis (penicillamine, pyrithioxin, thiopronine)].
    Camus JP; Prier A; Cassou B; Bergevin H
    Rev Prat; 1980 Apr; 30(23):1517-8, 1521-3. PubMed ID: 7384712
    [No Abstract]   [Full Text] [Related]  

  • 3. [Retrospective study of the effects of D-penicillamine and pyrithioxin in the treatment of rheumatoid arthritis].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):281-7. PubMed ID: 6879095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrithioxine and thiopronine: new penicillamine-like drugs in rheumatoid arthritis.
    Camus JP; Crouzet J; Prier A; Bergevin H
    J Rheumatol Suppl; 1981; 7():175-7. PubMed ID: 6939882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sulfhydryl maintenance treatment in rheumatoid polyarthritis. A series of 120 cases followed for 10 years and a study of possibilities of changing the drug].
    Camus JP; Koeger AC; Struz P; Laveant C
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):31-3. PubMed ID: 3704509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment of rheumatoid arthritis with pyrithioxin (Enerbol, Polfa)].
    Brühl W; Cygler B
    Reumatologia; 1979; 17(3):337-8. PubMed ID: 515579
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and immunological effects of treatment of rheumatoid arthritis with pyrithioxin (Enerbol Polfa)].
    Brühl W; Swierczyńska Z; Szymańska-Cygler B; Dyznarowska H; Chrzczonowski Z; Loth E; Zabek J
    Reumatologia; 1980; 18(3):241-8. PubMed ID: 6448464
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pyrithioxine a new basic treatment of rheumatoid polyarthritis: initial study of 72 cases with a 6-month follow-up].
    Camus JP; Jaffe IA; Crouzet J; Prier A; Mercier A; Dubois A
    Rev Rhum Mal Osteoartic; 1978 Feb; 45(2):95-100. PubMed ID: 644244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of 70 cases of rheumatoid polyarthritis treated by pyrithioxin with a 1-year follow-up].
    Camus JP; Crouzet J; Prier A; Bergevin H
    Rev Rhum Mal Osteoartic; 1978; 45(7-9):487-90. PubMed ID: 725465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephrotic syndrome related to the use of pyrithioxin in the treatment of rheumatoid arthritis].
    Amor B; Cherot A; Delbarre F
    Nouv Presse Med; 1979 Jun; 8(24):2023-4. PubMed ID: 492994
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pyrithioxine: a new basic treatment of rheumatoid arthritis. Open study of 60 cases with a follow-up of 6 months].
    Camus JP; Jaffe IA; Crouzet J; Prier A; Stephan JC; Laveant C
    Ann Med Interne (Paris); 1977 Dec; 128(12):907-11. PubMed ID: 603171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of chloroquine and D-penicillamine in the treatment of rheumatoid arthritis.
    Muirden KD
    Med J Aust; 1986 Jan; 144(1):32-4, 36-7. PubMed ID: 2867456
    [No Abstract]   [Full Text] [Related]  

  • 13. [Squamous eruption of the lichen planus histological type during treatment with pyritinol].
    Méraud JP; géniaux M; Tamisier JM; Delaunay MM; Texier L
    Ann Dermatol Venereol; 1980 Jun; 107(6):561-4. PubMed ID: 7425461
    [No Abstract]   [Full Text] [Related]  

  • 14. [The basic treatment of rheumatoid arthritis. Current trends].
    Suţeanu S; Manuchian M
    Med Interne; 1984; 22(4):241-51. PubMed ID: 6393302
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myasthenia induced by pyrithioxine during the treatment of rheumatoid arthritis].
    Kirjner M; Lebourges J; Camus JP
    Nouv Presse Med; 1980 Nov; 9(41):3098. PubMed ID: 7443460
    [No Abstract]   [Full Text] [Related]  

  • 16. [A trial of comparative effects of gold salts and D-penicillamine in rheumatoid arthritis].
    Nezić-Ivković J; Dürrigl T
    Reumatizam; 1978; 25(3):75-8. PubMed ID: 353935
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term comparative studies on gold, D-penicillamine, and NSAIDs for the treatment of early rheumatoid arthritis. 1. Evaluation of one year's treatment].
    Azuma T; Sugawara S; Maeda A; Miyauchi T; Aritomi H
    Ryumachi; 1986 Jun; 26(3):200-9. PubMed ID: 3097838
    [No Abstract]   [Full Text] [Related]  

  • 18. [Side effects of D-penicillamine and pyritinol. Cooperative study among French hospital drug surveillance centers].
    Netter P; Tréchot P; Bannwarth B; Faure G; Royer RJ
    Therapie; 1985; 40(6):475-9. PubMed ID: 4089789
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nephrotic syndrome during rheumatoid polyarthritis treated with pyrithioxin].
    Segond P; Dellas JA; Massias P; Delfraissy JF
    Rev Rhum Mal Osteoartic; 1979; 46(7-9):509-10. PubMed ID: 504954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pyrithioxin (Encephabol) in the treatment of patients with organic psychosyndrom in involution. Clinical, EEG and experimental psychological study (author's transl)].
    Misurec J; Sláma B; Náhunek K
    Cesk Psychiatr; 1976 Feb; 72(1):14-23. PubMed ID: 773551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.